Marshall and Dunaif Page 4
activating its own receptor and using inositoglycan mediators as the signal transduction system. J
Clin Endocrinol Metab. 1998; 83:2001–2005. [PubMed: 9626131]
8. Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary.
NIH-PA Author Manuscript
Endocrinol Metab Clin North Am. 1999; 28:361–378. [PubMed: 10352923]
9. Blank SK, McCartney CR, Chhabra S, Helm KD, Eagleson CA, Chang RJ, et al. Modulation of
GnRH pulse generator sensitivity to progesterone inhibition in hyperandrogenemic adolescent girls:
implications for regulation of pubertal maturation. J Clin Endocrinol Metab. 2009; 94:2360–2366.
[PubMed: 19351732]
10. Berga SL. Polycystic ovary syndrome: a model of combinational endocrinology. J Clin Endocrinol
Metab. 2009; 94:2250–2251. [PubMed: 19584198]
11. Kristiansen SB, Endoh A, Casson PR, Buster JE, Hornsby PJ. Induction of steroidogenic enzyme
genes by insulin and IGF-1 in cultured adult human adrenocortical cells. Steroids. 1997; 62:258–
265. [PubMed: 9055386]
12. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, et al. Insulin infusion amplifies 17
alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic
women: apparent relative impairment of 17, 20-lyase activity. J Clin Endocrinol Metab. 1996;
81:881–886. [PubMed: 8772544]
13. Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. Clin
Obstet Gynecol. 2007; 50:205–225. [PubMed: 17304037]
14. Ehrmann DA, Lijenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN, et al. Prevalence and
predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin
Endocrinol Metab. 2006; 91:48–53. [PubMed: 16249284]
NIH-PA Author Manuscript
15. Norman RJ, Davies MJ, Lord J, Moran LJ. The life style modification in polycystic ovary
syndrome. Trends Endocrinol Metab. 2002; 13:251–257. [PubMed: 12128286]
16. Hoeger KM. Exercise therapy in polycystic ovary syndrome. Semin Reprod Med. 2008; 26:93–
100. [PubMed: 18181087]
17. Ehrmann D, Schneider DJ, Sobel BE. Troglitazone improves defects in insulin action, insulin
secretion, ovarian steroidogenesis and fibrinolysis in women with polycystic ovary syndrome. J
Clin Endocrinol Metab. 1997; 82:2108–2116. [PubMed: 9215280]
18. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin sensitizing agent
troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
J Clin Endocrinol Metab. 1996; 81:3299–3306. [PubMed: 8784087]
19. Zhou G, Myers R, Li Y, Chen Y, Shen X. Role of AMP activated protein kinase in mechanism of
metformin action. J Clin Invest. 2001; 108:1167–1174. [PubMed: 11602624]
20. Bailey C, Turner R. Metformin. N Engl J Med. 1996; 334:574–579. [PubMed: 8569826]
21. Lord JM, Flight IHK, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and
meta-analysis. Brit Med J. 2003; 327:951–956. [PubMed: 14576245]
22. Creanga AA, Bradley HM, McCormick C, Witkop CT. Use of metformin in polycystic ovary
syndrome: a meta-analysis. Ob Gyn. 2008; 111:959–968.
NIH-PA Author Manuscript
23. Salpeter SR, Buckley NS, Kahn JA, Salpeter EE. Meta-analysis: metformin treatment in persons at
risk for diabetes mellitus. Am J of Med. 2008; 121:149–157. [PubMed: 18261504]
24. Ballargeon JP, Jakubowicz DJ, Iuomo MJ, Jakubowicz S, Nestler JE. Effects of metformin and
rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and
normal indices of insulin sensitivity. Fertil Steril. 2004; 82:893–902. [PubMed: 15482765]
25. Ortega-Gonzalez C, Luna S, Hernandez L, Crespo G, Aguayo P, Arteaga-Troncoso G, et al.
Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese,
insulin resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;
90:1360–1365. [PubMed: 15598674]
26. Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitizing drugs versus the
combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease,
and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst Rev. 2007;
1:CD005552. [PubMed: 17253562]
27. McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, et al. The
association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a
Fertil Steril. Author manuscript; available in PMC 2013 January 1.